Oberman Law Firm

OBERMAN LAW FIRM

updates

Page Under Construction.

Stuart Oberman Featured in the JD Journal

Oberman Law Firm is proud to announce that Stuart Oberman has been featured in The JD Journal as “Stuart Oberman: A Beacon of Legal Expertise and Healthcare Advocacy”.  The article celebrates Mr. Oberman’s remarkable journey in the legal field, showcasing over…

FTC Bans Non-Compete Agreements
24Apr

FTC Bans Non-Compete Agreements

The U.S. Federal Trade Commission (FTC) today approved a final rule banning most new noncompete clauses in employment contracts—this sweeping change will affect millions of workers. The rule also makes all existing noncompete agreements except for those covering senior executives…

New Emerging Markets Webinar on Ohio Adult Use Now Available
22Apr

New Emerging Markets Webinar on Ohio Adult Use Now Available

Exciting News! A new webinar featuring Stuart Oberman and Justin Moriconi discussing Ohio’s new Adult-Use Cannabis Law is now available on our website! Watch the recorded session to learn about the latest rules proposed by the Ohio Division of Cannabis…

Stuart Oberman Featured Article by GAGD
22Apr

Stuart Oberman Featured Article by GAGD

Exciting News for Dental Practice Owners! Stuart Oberman of Oberman Law Firm has authored an insightful article titled “Corporate Transparency Act – New Federal Law (Dental Practice Owners Beware)” featured by the Georgia Academy of General Dentistry (GAGD). The Corporate…

Federal Court in Virginia Upholds Virginia Law Restricting the Sale of Hemp Products
19Apr

Federal Court in Virginia Upholds Virginia Law Restricting the Sale of Hemp Products

The law, which went into effect on July 1, 2023, requires that all hemp products for sale in Virginia contain less than 0.3% total THC and prohibits the sale of intoxicating products, such as those containing delta-8.  The law was…

PTSD Treatment Set in Motion
18Apr

PTSD Treatment Set in Motion

On December 12, 2023, the Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation (“MAPS PBC”) announced that it has submitted a new drug application (“NDA”) to the FDA for the use of 3,4-Methylenedioxymethamphetamine (“MDMA”) for the treatment of post-traumatic stress disorder (“PTSD”).…

MORE RESOURCES

Sharing our knowledge and expertise.